Literature DB >> 21367720

Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.

Suk See De Ravin1, Malliswari Challipalli, Victoria Anderson, Yvonne R Shea, Beatriz Marciano, Dianne Hilligoss, Martha Marquesen, Rosamma Decastro, Yen-Chun Liu, Deanna A Sutton, Brian L Wickes, Patricia L Kammeyer, Lynne Sigler, Kathleen Sullivan, Elizabeth M Kang, Harry L Malech, Steven M Holland, Adrian M Zelazny.   

Abstract

BACKGROUND: Chronic granulomatous disease (CGD) is an inherited disorder of the nicotinamide adenine dinucleotide phosphate oxidase that leads to defective production of microbicidal superoxide and other oxidative radicals, resulting in increased susceptibility to invasive infections, especially those due to fungi.
METHODS: Geosmithia argillacea was identified from cultured isolates by genomic sequencing of the internal transcribed spacer region. Isolates previously identified as Paecilomyces variotii, a filamentous fungus closely resembling G. argillacea, were also examined.
RESULTS: We identified G. argillacea as the cause of invasive mycosis in 7 CGD patients. In 5 cases, the fungus had been previously identified morphologically as P. variotii. All patients had pulmonary lesions; 1 had disseminated lesions following inhalational pneumonia. Infections involved the chest wall and contiguous ribs in 2 patients and disseminated to the brain in 1 patient. Four patients with pneumonia underwent surgical intervention. All patients responded poorly to medical treatment, and 3 died.
CONCLUSIONS: We report the first cases of invasive mycosis caused by G. argillacea in CGD patients. G. argillacea infections in CGD are often refractory and severe with a high fatality rate. Surgical intervention has been effective in some cases. G. argillacea is a previously underappreciated and frequently misidentified pathogen in CGD that should be excluded when P. variotii is identified morphologically.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367720      PMCID: PMC3049339          DOI: 10.1093/cid/ciq250

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease.

Authors:  A Cohen-Abbo; K M Edwards
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

2.  Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child.

Authors:  Shih-Min Wang; Chi-Chang Shieh; Ching-Chuan Liu
Journal:  Diagn Microbiol Infect Dis       Date:  2005-09-15       Impact factor: 2.803

3.  Nucleotide polymorphisms associated with Internal Transcribed Spacer (ITS) regions of ocular isolates of Aspergillus flavus.

Authors:  R Bagyalakshmi; K Lily Therese; H N Madhavan
Journal:  J Microbiol Methods       Date:  2006-09-07       Impact factor: 2.363

4.  Identification of Paecilomyces variotii in clinical samples and settings.

Authors:  Jos Houbraken; Paul E Verweij; Anthonius J M M Rijs; Andrew M Borman; Robert A Samson
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

5.  Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.

Authors:  Sophia Siddiqui; Victoria L Anderson; Diane M Hilligoss; Mario Abinun; Taco W Kuijpers; Henry Masur; Frank G Witebsky; Yvonne R Shea; John I Gallin; Henry L Malech; Steven M Holland
Journal:  Clin Infect Dis       Date:  2007-08-08       Impact factor: 9.079

Review 6.  Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.

Authors:  John Dotis; Emmanuel Roilides
Journal:  Int J Infect Dis       Date:  2004-03       Impact factor: 3.623

Review 7.  Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease.

Authors:  E Roilides; L Sigler; E Bibashi; H Katsifa; N Flaris; C Panteliadis
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 8.  Aspergillus nidulans infection in chronic granulomatous disease.

Authors:  B H Segal; E S DeCarlo; K J Kwon-Chung; H L Malech; J I Gallin; S M Holland
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889

Review 9.  Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections.

Authors:  P R Williamson; K J Kwon-Chung; J I Gallin
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

10.  Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.

Authors:  David E Greenberg; Adam R Shoffner; Adrian M Zelazny; Michael E Fenster; Kol A Zarember; Frida Stock; Li Ding; Kimberly R Marshall-Batty; Richard L Wasserman; David F Welch; Kishore Kanakabandi; Dan E Sturdevant; Kimmo Virtaneva; Stephen F Porcella; Patrick R Murray; Harry L Malech; Steven M Holland
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

View more
  23 in total

1.  Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Anna F Lau; Steven K Drake; Leslie B Calhoun; Christina M Henderson; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

2.  Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Authors:  Abdelmounaim Mouhajir; Olivier Matray; Sandrine Giraud; Laurent Mély; Christophe Marguet; Isabelle Sermet-Gaudelus; Solène Le Gal; Franck Labbé; Christine Person; Françoise Troussier; Jean-Jacques Ballet; Gilles Gargala; Rachid Zouhair; Marie-Elisabeth Bougnoux; Jean-Philippe Bouchara; Loïc Favennec
Journal:  J Clin Microbiol       Date:  2016-09-07       Impact factor: 5.948

3.  In Vitro Activity of Isavuconazole against Rasamsonia Species.

Authors:  J Steinmann; S Dittmer; J Houbraken; J Buer; P-M Rath
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Rasamsonia argillacea pulmonary and aortic graft infection in an immune-competent patient.

Authors:  Jeffrey B Doyon; Deanna A Sutton; Pierre Theodore; Gurmohan Dhillon; Kirk D Jones; Elizabeth H Thompson; Jianmin Fu; Brian L Wickes; Jane E Koehler; Brian S Schwartz
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

5.  Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Authors:  J Houbraken; S Giraud; M Meijer; S Bertout; J C Frisvad; J F Meis; J P Bouchara; R A Samson
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

6.  Genetic Susceptibility to Fungal Infections: What is in the Genes?

Authors:  Stacey A Maskarinec; Melissa D Johnson; John R Perfect
Journal:  Curr Clin Microbiol Rep       Date:  2016-03-29

7.  [Primary immunodeficiency].

Authors:  K R Engelhardt; B Grimbacher; T Niehues
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

8.  The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.

Authors:  Naruhiko Ishiwada; Kenichi Takeshita; Takashi Yaguchi; Koo Nagasawa; Noriko Takeuchi; Haruka Hishiki; Akira Watanabe; Katsuhiko Kamei; Naoki Shimojo
Journal:  Mycopathologia       Date:  2015-11-13       Impact factor: 2.574

9.  Identification and Antifungal Susceptibility of Penicillium-Like Fungi from Clinical Samples in the United States.

Authors:  Marcela Guevara-Suarez; Deanna A Sutton; José F Cano-Lira; Dania García; Adela Martin-Vicente; Nathan Wiederhold; Josep Guarro; Josepa Gené
Journal:  J Clin Microbiol       Date:  2016-06-08       Impact factor: 5.948

10.  Paravertebral mushroom: identification of a novel species of Phellinus as a human pathogen in chronic granulomatous disease.

Authors:  Suk See De Ravin; Mark Parta; Deanna A Sutton; Brian L Wickes; Elizabeth H Thompson; Nathan P Wiederhold; Karen K Nakasone; Meghna Alimchandani; Amy OConnell; Luigi Notarangelo; Elizabeth Kang; Harry L Malech; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.